CytoDyn Inc. Quarterly Additional Paid in Capital in USD from Q2 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
Summary
CytoDyn Inc. quarterly Additional Paid in Capital history and growth rate from Q2 2011 to Q4 2024.
  • CytoDyn Inc. Additional Paid in Capital for the quarter ending November 30, 2024 was $786M, a 5.22% increase year-over-year.
Additional Paid in Capital, Quarterly (USD)
Additional Paid in Capital, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $786M +$39M +5.22% Nov 30, 2024 10-Q 2025-01-14
Q3 2024 $786M +$50.4M +6.86% Aug 31, 2024 10-Q 2024-10-15
Q2 2024 $774M +$42.4M +5.8% May 31, 2024 10-Q 2025-01-14
Q1 2024 $754M +$39.2M +5.48% Feb 29, 2024 10-Q 2024-04-15
Q4 2023 $747M +$54.9M +7.93% Nov 30, 2023 10-Q 2024-01-16
Q3 2023 $735M +$47.7M +6.94% Aug 31, 2023 10-Q 2023-10-23
Q2 2023 $731M +$60.3M +8.98% May 31, 2023 10-K 2024-08-15
Q1 2023 $715M +$56.8M +8.62% Feb 28, 2023 10-Q 2023-04-10
Q4 2022 $693M +$66M +10.5% Nov 30, 2022 10-Q 2023-01-09
Q3 2022 $688M +$114M +19.9% Aug 31, 2022 10-Q/A 2022-10-13
Q2 2022 $671M +$139M +26.1% May 31, 2022 10-K 2023-09-14
Q1 2022 $658M +$192M +41.1% Feb 28, 2022 10-K 2022-08-15
Q4 2021 $627M +$188M +43% Nov 30, 2021 10-K 2022-08-15
Q3 2021 $574M +$185M +47.7% Aug 31, 2021 10-K 2022-08-15
Q2 2021 $532M +$160M +42.9% May 31, 2021 10-K 2022-08-15
Q1 2021 $467M +$175M +59.9% Feb 28, 2021 10-K 2022-08-15
Q4 2020 $438M +$191M +77.6% Nov 30, 2020 10-K 2022-08-15
Q3 2020 $388M +$150M +62.9% Aug 31, 2020 10-Q 2020-10-09
Q2 2020 $372M +$147M +65.3% May 31, 2020 10-K 2022-08-15
Q1 2020 $292M +$84M +40.4% Feb 29, 2020 10-Q 2020-04-09
Q4 2019 $247M +$53.1M +27.4% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 $238M +$70.9M +42.3% Aug 31, 2019 10-Q 2019-10-08
Q2 2019 $225M +$65.4M +40.9% May 31, 2019 10-Q 2022-01-10
Q1 2019 $208M +$52.2M +33.5% Feb 28, 2019 10-Q 2019-04-09
Q4 2018 $194M +$60.9M +45.9% Nov 30, 2018 10-Q 2019-01-09
Q3 2018 $168M +$41.4M +32.8% Aug 31, 2018 10-Q 2018-10-09
Q2 2018 $160M +$38M +31.2% May 31, 2018 10-K 2019-08-14
Q1 2018 $156M +$34.3M +28.2% Feb 28, 2018 10-Q 2018-04-09
Q4 2017 $133M +$19.3M +17.1% Nov 30, 2017 10-Q 2018-01-08
Q3 2017 $126M +$17.4M +16% Aug 31, 2017 10-Q 2017-10-10
Q2 2017 $122M +$14.4M +13.4% May 31, 2017 10-K 2018-07-27
Q1 2017 $121M +$19.6M +19.3% Feb 28, 2017 10-Q 2017-04-13
Q4 2016 $113M +$30.4M +36.7% Nov 30, 2016 10-Q 2017-01-13
Q3 2016 $109M +$35.1M +47.7% Aug 31, 2016 10-Q 2016-10-12
Q2 2016 $107M +$46.5M +76.6% May 31, 2016 10-K 2017-07-20
Q1 2016 $102M +$80.5M +378% Feb 29, 2016 10-Q 2016-04-13
Q4 2015 $82.9M +$62M +297% Nov 30, 2015 10-Q 2016-01-11
Q3 2015 $73.6M +$53.4M +264% Aug 31, 2015 10-Q 2015-10-09
Q2 2015 $60.8M +$40.7M +202% May 31, 2015 10-K 2016-07-19
Q1 2015 $21.3M +$1.62M +8.23% Feb 28, 2015 10-Q 2015-04-10
Q4 2014 $20.9M +$1.5M +7.71% Nov 30, 2014 10-Q 2015-01-12
Q3 2014 $20.2M +$1.29M +6.8% Aug 31, 2014 10-Q 2014-10-10
Q2 2014 $20.1M +$2.32M +13.1% May 31, 2014 10-K 2015-07-10
Q1 2014 $19.7M +$2.95M +17.6% Feb 28, 2014 10-Q 2014-04-11
Q4 2013 $19.4M +$3.38M +21.1% Nov 30, 2013 10-Q 2014-01-13
Q3 2013 $18.9M +$9.32M +96.8% Aug 31, 2013 10-Q 2013-10-15
Q2 2013 $17.8M +$9.76M +122% May 31, 2013 10-K 2014-07-10
Q1 2013 $16.8M +$9.79M +140% Feb 28, 2013 10-Q 2013-04-12
Q4 2012 $16M +$9.35M +140% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 $9.63M +$3.51M +57.4% Aug 31, 2012 10-Q/A 2012-11-08
Q2 2012 $8.02M +$2.14M +36.5% May 31, 2012 10-K 2013-08-29
Q1 2012 $6.97M Feb 29, 2012 10-Q 2012-04-16
Q4 2011 $6.67M Nov 30, 2011 10-Q 2012-01-17
Q3 2011 $6.12M Aug 31, 2011 10-Q/A 2011-11-30
Q2 2011 $5.88M May 31, 2011 10-K 2012-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.